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Abstract. Expression of hepatocyte growth factor (HGF) and 
its receptor, c-met is up-regulated in various forms of liver 
injury. This study evaluated the relationship between HGF and 
c-met expression and pathological changes in experimental 
alcoholic liver disease. Rats (5 per group) were fed ethanol and 
a diet containing saturated fat corn oil or fish oil by intragastric 
infusion. Dextrose isocalorically replaced ethanol in controls. 
In a second set of experiments, Kupffer cells, endothelial cells 
and hepatocytes were isolated from rats in each group. Patho­
logical evaluation and analysis of HGF and c-met expression 
were performed in liver and the different cell types. Increased 
expression of HGF and c-met expression was detected in the 
liver of rats showing necroinflammatory changes. The Kupffer 
and endothelial cells were primarily responsible for the 
increase in HGF, c-met expression was seen only in hepato­
cytes. Thus, up-regulation of HGF and c-met occurred in the 
presence of the necrosis and inflammation suggesting that HGF 
may be acting to protect against liver injury or accelerate the 
regenerative process. 
Introduction 
Hepatocyte growth factor (HGF) is the most powerful 
hepatocyte mitogen in vitro (1) and it is also an extremely 
potent mitogen, motogen, and morphogen in vivo (2-4). HGF 
was first detected in the serum of both normal and partially 
hepatec tomised rats and was subsequent ly cloned and 
sequenced by Nakamura et al (5). It has since been established 
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that HGF is expressed by various mesenchymal-derived cells 
throughout the body, but is produced in the liver by Kupffer, 
endothelial and hepatic stellate cells (6). HGF produces its 
biological effects by activating the transmembrane c-met 
receptor (7-9), which on binding HGF, dimerises and cross 
phosphorylates its intracellular tyrosine kinase sites, intiating 
the signal transduction cascade which culminates in effecting 
the mitogenic, motogenic and morphogenic properties of its 
ligand (10). The exact mechanisms of these downstream effects 
are not as yet fully elucidated. 
The presence of necrosis and an inflammatory response 
characterizes alcoholic liver disease (ALD). Since several lines 
of investigation indicate that HGF is up-regulated in response 
to hepatic injury (3), the aim of this study was to identify the 
pattern of HGF and c-met expression in liver tissue and the 
different cell types in alcohol-treated rats. We utilized the rat 
model of intragastric feeding to induce alcoholic liver injury 
(11,12) and to determine whether any such relationship might 
exist between ALD and expression of HGF and c-met. This 
strategy was employed primarily because the severity of injury 
induced in the intragastric feeding model can be varied simply 
by changing the type of dietary fat. For instance, based on 
epidemiological studies relating to the nature of the dietary 
fat and incidence of ALD (13) experimental studies have 
demonstrated that rats fed saturated fatty acids and ethanol 
develop none of the histological features of ALD (14) whereas 
rats fed polyunsaturated fatty acids and ethanol show fatty 
liver, necrosis, inflammation and fibrosis (15). Moreover, if 
fish oil is fed with ethanol, the necrosis, inflammation and 
fibrosis is much more severe than is seen in rats fed corn oil 
and ethanol (16-18). 
Thus, the ability to induce various grades of alcoholic liver 
injury enabled us to relate the severity of liver damage to any 
concomitant fluctuation in HGF or c-met expression between 
the different dietary groups. Analysis of transcription of both 
HGF and c-met genes was performed by in situ hybridization 
(ISH) on formalin-fixed paraffin-embedded liver, in addition 
to mRNA analysis by reverse transcription polymerase chain 
reaction (RT-PCR) of liver tissue and purified parenchymal 
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Table I. Blood alcohol levels (mean + SE) and pathological changes in the different experimental groups. 
Experimental group Blood alcohol (mg/dl) Fatty liver (0-4) Necrosis (foci/LPF) Inflammation foci/LPF 
MCTD 
MCTE 
CD 
CE 
FD 
FE 
0 
242+47 
0 
249±37 
0 
244±45 
0 
0 
0 
3.4+0.5 
0 
4.0±0.0 
0 
0 
0 
l .2±0.4b 
0 
2.0±0.0a 
0 
0 
0 
1.2+0.4" 
0 
2.0+0.0" 
ap<0.05 vs. CE, p<0.01 vs MCTE; bp<0.01 vs MCTE. MCT, medium chain triglycerides; C, corn oil; F, fish oil; D, dextrose; E, ethanol. 
and non-parenchymal liver cell populations obtained from the 
rats in the different dietary groups. 
Materials and methods 
Animals. All animals used for this study were cared for in 
accordance with the National Institutes of Health criteria for 
care of laboratory animals. Six groups of male Wistar rats (five 
rats per group) weighing 275-300 g were fed by continuous 
infusion of a liquid diet via permanently implanted gastric 
tubes, as previously described (11,12). The six diets were 
constituted as follows: medium chain triglycerides, corn oil or 
fish oil, each being supplemented with either dextrose 
(MCTD,CD and FD) or ethanol (MCTE, CE and FE) 
respectively. Dietary fatty acids contributed 35% of total 
caloric intake and the fatty acid composition of these diets 
has been described previously (17). Ethanol was initially 
administered at a dose of 10 g/kg/day and was gradually 
increased to 16 g/kg/day as tolerance developed. Blood alcohol 
levels were maintained at between 150 and 300 mg/dl; blood 
was collected from the tail vein and ethanol concentration 
measured using an alcohol dehydrogenase assay (Sigma). All 
rats were sacrificed four weeks after initiating each feeding 
regime and the liver was processed as described below. 
Isolation of hepatocytes, Kupffer cells and endothelial cells. 
Detailed descriptions of the cell isolation and purification 
procedures have already been published (19,30). Briefly, livers 
were exsanguinated in situ, excised and finely minced and 
incubated in 0.05% collagenase at 37°C for 45 min. Each of 
the three cell populations were thereafter isolated and their 
identities confirmed using, morphological criteria and immuno-
histochemical analyses (19). The purified cell populations were 
stored at -70°C until required for RNA isolation and RT-PCR. 
Analysis of HGF, c-met and fJ-actin expression in whole tissue 
and cells by RT-PCR. Total RNA was isolated from both 
whole liver tissue and the purified cell populations according 
to the guanidium isothiocyanate method (8). The integrity of 
isolated RNA was determined by agarose gel electophoresis 
and ethidium bromide staining. Total RNA (0.5-1.0 |ig) was 
reverse transcribed and the resultant HGF, c-met and B-actin 
cDNAs were amplified using the conditions described 
previously (19). The sequences of the primers used in this 
study have been previously published (20,21). Negative 
controls for each experiment consisted of analyzing a 
sample of total RNA which had not undergone reverse 
transcription. 
PCR products and appropriate molecular weight markers 
were electrophoresed on a 1 % agarose gel and after staining 
with ethidium bromide were analysed by laser scanning 
densitometry (Molecular Dynamics, Sunnyvale, CA). None of 
the negative control samples yielded any product, confirming 
the absence of contaminating DNA species. 
Histopathological analysis. Small samples of exsanguinated 
livers were fixed overnight in formalin, routinely processed 
and embedded in paraffin wax. Five micron sections were cut 
from these blocks, processed for routine haematoxylin and 
eosin (H&E) staining and the severity of pathological 
changes (i.e. extent of steatosis, necrosis and inflammation) 
were ascertained as previously described (14,18). Briefly the 
degree of steatosis was graded according to the percentage 
of liver cells containing fat and necrosis and inflammation 
according the number of foci per power field. 
In situ hybridization for HGF and c-met mRNAs. The method 
described is based on that by Senior et al (22) with slight 
modifications (23). Each sample was prepared in duplicate so 
that two exposure times to the emulsion (14 and 28 days) could 
be performed. Plasmids containing cDNA for regions of rat 
HGF (rHGF) (Eco RI subclone from RBC1 in pBluescript SK 
vector) were kindly provided by Dr T. Nakamura, Kyushu 
University, Fukuoka, Japan; the mouse c-met (SphI - Sad 
subclone into Bluescribe), was kindly provided by Dr Laki 
Buluwela, Charing Cross & Westminster Medical School, 
London, UK; and the rat 6-actin control was produced and 
provided by Dr Rebecca Chinery, ICRF Histopathology Unit, 
London, UK. These plasmids were used to produce antisense 
riboprobes internally labeled with approximately 800 Ci/mmol 
of (24) serum. 
The rHGF probe of approximately 1.4 kb was generated 
from Eco RV restriction enzyme linearised plasmid; mouse 
c-met probe of 0.79 kb was generated from Hindlll linearised 
plasmid, and rat B-actin probe of 0.24 kb was generated from 
Eco RI restriction enzyme linearised plasmid. The probes were 
transcribed using T3 (rHGF and B-actin) or T7 (c-met) RNA 
polymerases (Promega). In vitro transcription using 0.5 mg 
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Figure 1. Densitometric analysis for HGF mRNA normalized using 13-actin in 
(A) livers, (B) endothelial cells and (C) Kupffer cells in the different treatment 
groups. Ethanol administration led to significant increases (p<0.01) in HGF 
mRNA in the liver, endothelial cells and Kupffer cells in the corn oil and 
fish oil groups but not in the MCT group. HGF mRNA was not detected in 
hepatocytes. *p<0.05 vs. MCTD, MCTE, CD; *p<0.05 vs. all other groups. 
of probe template, 5U RNA polymerase per mg of template, 
1 mM each of ATP, GTP, CTP and 14 mM of 35S-UTP 
(Amersham) was carried out for 1 h at 37°C. The probe 
template was then destroyed by incubation for 15 min at 37°C 
with 1ml of RNAse-free DNAse I (Boehringer) and the 
labeled probe then purified using a Chromaspin-30 column 
(Clontech Laboratories). 
Sections (4 mm thick) of formalin fixed, paraffin embedded 
livers were de-waxed, hydrated through DEPC-treated graded 
ethanol and washed in PBS. Sections were then permeabilised 
at 37°C with 20 mg/ml Proteinase K in PBS for 10 min, rinsed 
in PBS and post-fixed for 20 min in 4% w/v paraformaldehyde 
in PBS. Sections were then rinsed briefly in three changes of 
PBS, dehydrated through graded ethanols and air-dried. 
The sections were then hybridized overnight at 55°C and 
processed through post hybridization and stringency washes 
as previously described (23). Autoradiography was carried out 
using standard procedures and the sections were subsequently 
Figure 2. Densitometric analysis for c-met mRNA normalized using B-actin in 
(A) liver and (B) hepatocytes in the different treatment groups. Ethanol 
administration led to significant increases (p<0.01) in c-met mRNA in the liver 
and hepatocytes in the corn oil-ethanol and fish oil-ethanol group, c-met 
mRNA was not detected in Kupffer and endothelial cells. *p<0.01 vs. 
dextrose fed groups and MCTE. 
counterstained with 1% v/v Giemsa solution, air-dried and 
mounted in Pertex. Patterns of hybridization was studied under 
both light-field and dark-field (reflected light) conditions. 
Statistical analysis. All data are expressed as means + SD 
unless stated otherwise. Differences between the groups were 
analyzed using analysis of variance with post hoc analysis 
using the Bonferroni test. 
Results 
Weight gain, blood alcohol levels and histopathology. All of 
the rats gained weight over the experimental period and no 
significant difference in weight gain was detected between 
the ethanol-treated and control groups, nor was there any 
significant difference in the mean blood alcohol levels in the 
ethanol treated rats (Table I). 
As previously observed (19), no pathological changes were 
seen in either the dextrose-fed control groups (MCTD, FD and 
CD) or in those animals receiving medium chain triglycerides 
and ethanol (MCTE). Injury was detected in corn oil and fish 
oil, ethanol-fed animals with the pathological profile being 
more severe in those rats which had received fish oil and 
ethanol (FE) (Table I). 
Expression of HGF and c-met mRNAs. The relative abundance 
and cellular origin of HGF and c-met transcripts were 
examined by RT-PCR analysis of whole liver homogenates 
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Figure 3. In situ hybridization for HGF in a liver from a rat on a fish oil ethanol (FE) diet showing scattered HGF labeling of cells adjacent to the sinusoids, 
but not hepatocytes. Original magnification x250. 
and purified populations of hepatocytes, endothelial cells and 
Kupffer cells. Fig. 1 displays the relative abundance of HGF 
mRNA in whole liver and demonstrates that HGF expression 
increased significantly only in rats fed ethanol in combination 
with either fish oil or corn oil. The FE diet was clearly the most 
significant inducer of HGF expression. Moreover, similar 
analyses of c-met expression showed an identical pattern with 
significant increases in the CE and FE groups and the largest 
increase was in the FE group (Fig. 2). 
These observations in whole liver are further supported by 
the RT-PCR results pertaining to the purified cell populations 
(Figs. 1 and 2), which clearly demonstrates that HGF is 
expressed by the endothelial and Kupffer cells. As was seen 
with whole liver, the level of expression in both cell types was 
highest in the FE treated livers. Expression of c-met on the 
other hand was confined only to hepatocytes which had been 
isolated from ethanol fed rats (Fig. 2). Of note is that both 
HGF and c-met mRNAs were detected in all of the whole liver 
homogenates, yet neither mRNA species was detectable in 
any of the purified cell populations isolated from those rats 
receiving the dextrose containing diets. This apparent anomaly 
can, however, be explained by the fact that HGF and c-met 
transcripts are expressed in normal liver principally by the 
stellate (Ito) cells (14) and cholangiocytes (15) respectively, 
cell types which had not been purified in this study. 
In situ hybridization for HGF confirmed the results 
obtained by RT-PCR analysis and revealed that in animals 
fed ethanol in combination with either fish oil or corn oil, there 
was strong labeling for HGF of non-hepatocyte cells scattered 
in the parenchyma (Fig. 3). Higher power fields revealed that 
these cells were adjacent to the sinusoids, in a distribution 
consistent with Kupffer and sinusoidal endothelial cells, 
although there were identifiable unlabelled sinusoidal 
endothelial cells (Fig. 4). 
c-met expression was only consistently detected in the 
same groups of animals in which HGF was demonstrable by 
ISH (FE and CE) (Fig. 5). Livers from animals in both these 
groups showed c-met labeling predominantly over hepatocytes 
with no enhancement of labeling of sinusoidal lining cells. 
There was very little background labeling. There was no 
labeling for c-met in the dextrose-fed groups or rats fed ethanol 
with medium chain triglycerides (data not shown). 
Discussion 
HGF was originally discovered to be a potent mitogenic 
factor for hepatocytes, and it is known to additionally possess 
a multitude of functions, inducing mitogenic, motogenic, 
morphogenic and tumoricidal effects upon a variety of cell 
types. HGF transduces these multiple biologic effects via 
activation of the transmembrane tyrosine kinase c-met receptor 
(7-9). In the liver, c-met is only expressed in hepatocytes and 
cholangiocytes, while HGF expression is restricted to the 
mesenchymal cells, primarily the stellate, Kupffer and endo­
thelial cell populations (25,26). 
The important finding in this study was that HGF gene 
expression was up-regulated in ethanol-fed rats, which develop 
liver injury. Furthermore, RT-PCR analysis of purified cell 
populations confirmed that the Kupffer and endothelial cells 
were responsible for this increased HGF expression. Although 
there are criticisms of PCR-based approaches to the 
quantitation of specific mRNAs, our results by RT-PCR are 
supported by in situ hybridization studies on liver tissue. The 
hepatocytes concomitantly up-regulated c-met expression, 
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 15: 811-817, 2005 815 
Figure 4. A higher power view of the same liver as Fig. 3 shows strong labeling for HGF (>100 grains/cell) ol' sinusoidal and endothelial cells. Original 
magnification x400. 
Figure 5. In situ hybridization for c-met in a liver from a rat fed corn oil ethanol (CE) showing fatty change and c-met labeling predominantly over 
hepatocytes with no enhancement of labeling of sinusoidal lining cells and little background labeling. The central vein is seen at the top right of the field. 
Original magnification x400. 
suggesting the possibility that increased c-met was responsive 
to the increased levels of HGF. 
Studies using other models of liver injury have also shown 
HGF expression to be up-regulated in both Kupffer and 
endothelial cells (27,28). For example, carbon tetrachloride 
administration stimulates a dramatic increase in HGF 
expression by endothelial cells but not in Kupffer or stellate 
cells (29). However, the present study showed that both 
endothelial and Kupffer cells (stellate cells were not isolated) 
up-regulated HGF expression in this model, an inconsistency 
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possibly related to the different time scales of the two studies. 
For instance, Maher sampled livers between 2 and 48 h after 
administration of the hepatotoxin (29), whereas our study 
analysed cells one month after ethanol administration. It is 
therefore possible that HGF expression by specific cell types 
after injury is sequential, and thus time-dependent, and/or is 
governed by the experimental model employed. 
The exact mechanism(s) leading to hepatic HGF up-
regulation in ethanol-fed rats is unknown, although increased 
expression of this growth factor is a phenomenon commonly 
associated with liver damage. For example, HGF expression 
increases dramatically in Long Evans Cinnamon rats which 
develop fulminant hepatitis (30), and similary in rats after 
galactosamine or carbon tetrachloride poisoning where the 
extent of liver damage has been shown to correlate directly 
with the level of HGF expression (29-31). It has also been 
demonstrated that the production of HGF activator, a serine 
protease, is increased in response to tissue injury as a result 
of an inflammatory response. HGF activator is responsible for 
localized activation of HGF in injured tissue (32). The 
discovery that transcription of the HGF and c-met genes is 
promoted in stromal and epithelial cells respectively, by 
inflammatory cytokines such as TNF-a and IL-1, supports the 
notion that both HGF and its receptor are involved, at least in 
part, in the mediation of inflammatory responses associated 
with liver injury (33). TNF-a and IL-1 levels are increased 
during ALD in man (34,35) and TNF-a mRNA expression also 
is increased in the livers of rats receiving unsaturated fatty 
acids and ethanol (36). 
In addition to its described hepatotrophic and biological 
activities, HGF may also have a cytoprotective role to play 
during a hepatotoxic insult. For example, HGF antagonizes 
interferon-y-induced hepatotoxici ty in cultured mouse 
hepatocytes (37), and an in vitro study has shown that HGF 
antagonizes the effects of IL-6 in inducing acute phase 
proteins in the liver (38). Similar effects have also been noted 
in vivo; a continuous supply of circulatory HGF produced by 
intrasplenically transplanted fibroblasts prevents carbon 
tetrachloride-induced liver damage in rats (39) and intra­
venous injections of recombinant human HGF suppress the 
progression of dimethylnitrosamine-induced hepatic injury and 
fibrosis (27). HGF also protects against liver injury caused by 
galactosamine and lipopolysaccharide (24,40). Although the 
exact mechanism for the protective effect of HGF is unknown, 
HGF increases glutathione in the liver (41) and also inhibits 
hepatocyle apoptosis (42). 
The increased expression of c-met in hepatocytes of 
ethanol-fed rats is likely to be secondary to increased HGF 
production (43). HGF increases the expression of c-met which 
consequently amplifies the stimulus and, therefore, response of 
its target cells (43). Indeed, such an augmented response has 
also been observed in the regenerating livers of rats treated 
with carbon tetrachloride (44). 
Overall, our results show that up-regulation of HGF and its 
receptor c-met, is most prominent in rats developing the most 
severe injury. Although the casual relationships between 
HGF and c-met expression and liver injury are uncertain, we 
can speculate however, that HGF may be acting to protect the 
liver from further damage (45). Additionally, HGF may 
accelerate the regenerative process, a view supported by 
others (12,46). We should, however, point out that the degree 
of cell regen-eration was not evaluated in the present study 
but other investigators have shown that hepatic regeneration 
occurs in rats fed unsaturated fatty acids and ethanol (47). 
Clearly, HGF is not the only mediator of such responses, as 
several factors have been implicated to be of importance in 
alcoholic liver injury. Thus, the complexity of the multitude 
of interactions taking place between these molecules must be 
taken into account. Hepatocyle growth factor is only one of 
the many mediators which regulate the liver's response to 
a lcohol ic insult, and thus its interplay with the other 
regenerative factors is a particularly important area for 
continued investigation. 
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